Allergan Must Face FCA Suit Over Drug Samples, Rx Pads

Law360, New York (April 3, 2017, 8:15 PM EDT) -- A New York federal judge largely upheld a whistleblower’s False Claims Act suit accusing Allergan Inc. of bribing doctors to prescribe eye care products by providing drug samples and prescription pads, and then wrongly firing the former employee, dismissing only some state claims.

In an 89-page ruling, U.S. District Judge Jesse M. Furman said the suit wasn’t barred by the FCA's public disclosure or first-to-file bar, even though similar litigation had been brought before, and said the suit meets the FCA’s standards. John Wood filed the...
To view the full article, register now.




Case Information

Case Title

United States of America ex rel. v. Allergan, Inc.

Case Number



New York Southern

Nature of Suit

Other Statutory Actions


Jesse M. Furman

Date Filed

July 26, 2010

Law Firms


Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.